60 Degrees Pharmaceuticals, Inc.
SXTP
$2.93
-$0.08-2.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 261.40K | 148.10K | 125.70K | 146.10K | 42.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 261.40K | 148.10K | 125.70K | 146.10K | 42.70K |
| Cost of Revenue | -1.03M | 1.05M | 3.18M | 402.60K | -252.90K |
| Gross Profit | 1.29M | -903.60K | -3.06M | -256.50K | 295.60K |
| SG&A Expenses | 1.61M | 1.22M | 1.13M | 1.08M | 1.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.34M | 2.27M | 4.31M | 1.48M | 1.94M |
| Operating Income | -2.08M | -2.12M | -4.19M | -1.33M | -1.89M |
| Income Before Tax | -2.05M | -2.16M | -4.17M | 428.00K | -2.05M |
| Income Tax Expenses | -500.00 | 300.00 | 400.00 | 100.00 | 100.00 |
| Earnings from Continuing Operations | -2.05M | -2.16M | -4.17M | 428.00K | -2.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.90K | 700.00 | 1.50K | 2.50K | 33.90K |
| Net Income | -2.05M | -2.16M | -4.17M | 430.50K | -2.01M |
| EBIT | -2.08M | -2.12M | -4.19M | -1.33M | -1.89M |
| EBITDA | -2.06M | -2.10M | -4.18M | -1.32M | -1.88M |
| EPS Basic | -2.28 | -4.66 | -21.14 | 1.85 | -21.97 |
| Normalized Basic EPS | -1.34 | -2.76 | -12.85 | 1.60 | -12.52 |
| EPS Diluted | -2.28 | -4.66 | -21.14 | 1.85 | -21.97 |
| Normalized Diluted EPS | -1.34 | -2.76 | -12.85 | 1.60 | -12.52 |
| Average Basic Shares Outstanding | 955.80K | 488.60K | 203.00K | 168.70K | 97.00K |
| Average Diluted Shares Outstanding | 955.80K | 488.60K | 203.00K | 168.70K | 97.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |